Showing results (311-320 of 390) with videos related to
Sort By:
Pageof 39
JAMA|January 30, 2004
Effect of breast augmentation on the accuracy of mammography and cancer characteristicsDiana L Miglioretti, Carolyn M Rutter, Berta M Geller, et al.The Lancet. Neurology|November 23, 2020
Safety and efficacy of MD1003 (high-dose biotin) in patients with progressive multiple sclerosis (SPI2): a randomised, double-blind, placebo-controlled, phase 3 trialBruce A C Cree, Gary Cutter, Jerry S Wolinsky, et al.The New England Journal of Medicine|September 30, 2016
Adjunctive Azithromycin Prophylaxis for Cesarean DeliveryAlan T N Tita, Jeff M Szychowski, Kim Boggess, et al.Muscle & Nerve|May 7, 2021
Telemedicine visits in myasthenia gravis: Expert guidance and the Myasthenia Gravis Core Exam (MG-CE)Amanda C Guidon, Srikanth Muppidi, Richard J Nowak, et al.The Lancet. Neurology|April 28, 2022
Comparison of switching to 6-week dosing of natalizumab versus continuing with 4-week dosing in patients with relapsing-remitting multiple sclerosis (NOVA): a randomised, controlled, open-label, phase 3b trialJohn F Foley, Gilles Defer, Lana Zhovtis Ryerson, et al.Journal of the National Cancer Institute|October 17, 2002
Detection of ductal carcinoma in situ in women undergoing screening mammographyVirginia L Ernster, Rachel Ballard-Barbash, William E Barlow, et al.The American Journal of the Medical Sciences|July 6, 2022
Satisfaction with modes of telemedicine delivery during COVID-19: A randomized, single-blind, parallel group, noninferiority trialMaria I Danila, Dongmei Sun, Lesley E Jackson, et al.Journal of the Neurological Sciences|March 19, 2010
Natalizumab plus interferon beta-1a reduces lesion formation in relapsing multiple sclerosisErnst-Wilhelm Radue, William H Stuart, Peter A Calabresi, et al.Neurology|September 14, 2019
Risk of natalizumab-associated PML in patients with MS is reduced with extended interval dosingLana Zhovtis Ryerson, John Foley, Ih Chang, et al.Movement Disorders : Official Journal of the Movement Disorder Society|February 25, 2020
Randomized, Controlled Trial of Exercise on Objective and Subjective Sleep in Parkinson's DiseaseAmy W Amara, Kimberly H Wood, Allen Joop, et al.Pageof 39